Our work in pharmaceutical systems, medicine access, and regulatory innovation.

This section presents selected Apotheker experience that fits the consultancy website: projects and technical assignments connected to medicine quality, ADDO systems, digital pharmacy tools, pharmaceutical market access, regulatory support, and health product systems strengthening.

Portfolio focus

Consultancy-relevant works selected from Apotheker’s public portfolio.

Only works that support the consultancy identity are featured.
We collaborate with local and international partner organizations working in the health sector to contribute our expertise through consultancy services. Over the decade, Apotheker has worked with organizations such as Management Sciences for Health (MSH) to advocate the ADDO model and provide technical support to those who developed interest in the model.

Reframing public portfolio experience for a professional consultancy website.

Apotheker  provided technical support to MSH through subcontract to work with the Ministry of Health Tanzania under Tanzania Medicines and Medical Devices Regulatory Authority (TMDA) and Pharmacy Council Tanzania to host visits from  Countries such as Uganda, Malawi, Zambia, Madagascar, Liberia, Nigeria, Bangladesh, Ghana, Burundi and Sierra Leone. 

Apotheker was also subcontracted by MSH to provide technical support to Countries such as Liberia, Zambia, Burundi, Bangladesh and Nigeria to work with regulatory authorities in the respective countries in developing documents and materials necessary for initiating the ADDO like model in those Countries.  Apotheker has also provided technical support to Results for Development (R4D) to evaluate the penetration of Amoxicillin DT in ADDOs in Tanzania, Iplus Solutions for a feasibility study on establishment of online pharmaceutical marketplace in Tanzania; Kilimanjaro School of Pharmacy to evaluate the expansion services for the infusion Unit;, Swiss National Science Foundation on iCHF services and membership perceptions to inform strategies to improve enrolment.

Consultancy-relevant experience from Apotheker’s portfolio.

Each work below has been rewritten in a professional consultancy style and mapped to the type of service it supports on the current Apotheker Consultancy website.

Medicine Quality

Regulatory Innovation

Paper Analytical Device for Medicine Quality Testing

Apotheker collaborated with the University of Notre Dame and TFDA on engaging private-sector medicine outlets and TFDA drug inspectors to introduce Paper Analytical Device technology for medicine quality testing.

Best fit on consultancy website

Digital Pharmacy Systems • Capacity Building • Operational Improvement

Medicine Quality

Regulatory Innovation

Paper Analytical Device for Medicine Quality Testing

Apotheker collaborated with the University of Notre Dame and TFDA on engaging private-sector medicine outlets and TFDA drug inspectors to introduce Paper Analytical Device technology for medicine quality testing.

Best fit on consultancy website

Digital Pharmacy Systems • Capacity Building • Operational Improvement

Medicine Quality

Regulatory Innovation

Paper Analytical Device for Medicine Quality Testing

Apotheker collaborated with the University of Notre Dame and TFDA on engaging private-sector medicine outlets and TFDA drug inspectors to introduce Paper Analytical Device technology for medicine quality testing.

Best fit on consultancy website

Digital Pharmacy Systems • Capacity Building • Operational Improvement

Medicine Quality

Regulatory Innovation

Paper Analytical Device for Medicine Quality Testing

Apotheker collaborated with the University of Notre Dame and TFDA on engaging private-sector medicine outlets and TFDA drug inspectors to introduce Paper Analytical Device technology for medicine quality testing.

Best fit on consultancy website

Digital Pharmacy Systems • Capacity Building • Operational Improvement

Medicine Quality

Regulatory Innovation

Paper Analytical Device for Medicine Quality Testing

Apotheker collaborated with the University of Notre Dame and TFDA on engaging private-sector medicine outlets and TFDA drug inspectors to introduce Paper Analytical Device technology for medicine quality testing.

Best fit on consultancy website

Digital Pharmacy Systems • Capacity Building • Operational Improvement

Medicine Quality

Regulatory Innovation

Paper Analytical Device for Medicine Quality Testing

Apotheker collaborated with the University of Notre Dame and TFDA on engaging private-sector medicine outlets and TFDA drug inspectors to introduce Paper Analytical Device technology for medicine quality testing.

Best fit on consultancy website

Digital Pharmacy Systems • Capacity Building • Operational Improvement

Afya-Tek as a systems
innovation case.

For the consultancy website, Afya-Tek should be positioned carefully as relevant technical experience in digital-enabled health systems, ADDO linkage, training, stakeholder collaboration, and public-private provider coordination — not as the main NGO identity.

213,782

Registered in the AfyaTek system

3,000

Referrals from ADDOs to health facilities

500+

Users trained and provided with digital tools

How these works support the consultancy brand.

The selected works should be organized around themes that strengthen Apotheker Consultancy’s commercial and technical positioning rather than presenting them as general NGO programming.

Regulatory and Medicine Quality

Works such as PAD medicine quality testing show technical relevance to regulatory inspection, product quality, and compliance systems.

ADDO and Community Pharmacy Systems

ADDO-related work demonstrates practical experience with private-sector drug outlets, training, supervision, and pharmacy service models.

Digital Pharmacy and Market Systems

PointMed, online pharmaceutical marketplace feasibility, and Afya-Tek show experience in digital tools and data-enabled service delivery.

Medicine Access and Feasibility Studies

MedSource, Amoxicillin-DT, and iCHF-ADDO work support the consultancy’s capability in assessment, evaluation, and market access advisory.